Bgm (BGM) Long-Term Investments (2019 - 2025)
Bgm's (BGM) quarterly Long-Term Investments came in at $11.5 million in Q3 2025, up 242.14% year-on-year from $3.4 million in Q3 2024, and up 264.5% on a QoQ basis from $3.2 million in Q1 2025.
Bgm (BGM) Long-Term Investments (2019 - 2025) Analysis & Trends
Bgm (BGM) has 7 years of Long-Term Investments data on file, last reported at $11.5 million in Q3 2025.
- On a quarterly basis, Long-Term Investments rose 242.14% year-over-year to $11.5 million in Q3 2025; TTM through Sep 2025 was $11.5 million, a 242.14% increase from a year earlier, with the FY2025 full-year figure at $11.5 million, up 242.14% from the prior year.
- Long-Term Investments for Q3 2025 stood at $11.5 million, up from $3.2 million in the prior quarter.
- Over the last five years, Long-Term Investments for BGM reached as high as $681.8 billion in Q1 2022 and fell as low as $606005.0 in Q3 2023.
- Historically, Long-Term Investments has averaged $210.0 billion across 5 years, with a median of $3.4 million in 2024.
- Across the five-year window, Long-Term Investments decreased 10.38% in 2023 and surged 454.42% in 2024, its largest moves.
- Year by year, Long-Term Investments stood at $639466.0 in 2021, then decreased by 3.42% to $617570.0 in 2022, then slipped by 1.87% to $606005.0 in 2023, then jumped by 454.42% to $3.4 million in 2024, then soared by 242.14% to $11.5 million in 2025.
- Per Business Quant data, the three most recent Long-Term Investments figures were $11.5 million in Q3 2025, $3.2 million in Q1 2025, and $3.4 million in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 56.09 Mn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 1.32 Bn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | 12.05 Mn |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 146.10 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Bgm | 33.55 Mn | 23.73 Mn | - | 11.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 11.50 Mn |
| Mar 31, 2025 | 3.15 Mn |
| Sep 30, 2024 | 3.36 Mn |
| Sep 30, 2023 | 606,005.00 |
| Mar 31, 2023 | 611.03 Bn |
| Sep 30, 2022 | 617,570.00 |
| Mar 31, 2022 | 681.82 Bn |
| Sep 30, 2021 | 639,466.00 |
| Mar 31, 2021 | 596.99 Bn |
| Sep 30, 2020 | 540,517.00 |
| Sep 30, 2019 | 539,680.00 |